Medical Countermeasures What is Thrombocytopenia, the Rare Condition Possibly Linked to the AstraZeneca Vaccine? by Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos April 8, 2021
Medical Countermeasures National Vaccine Trial Will Focus on Those with History of Severe Allergies or Mast Cell Disorder by Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos April 7, 2021
Medical Countermeasures New Insights on Cause of Rare Anaphylaxis Following COVID-19 Vaccination by Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos April 7, 2021
Medical Countermeasures How Good Is the AstraZeneca Vaccine – And Is It Really Safe? by Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos March 23, 2021
Medical Countermeasures How Effective is the First Shot of the Pfizer or Moderna Vaccine? by Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos March 20, 2021
Medical Countermeasures Applying Lessons from Annual Flu Vaccine Strain Selection to COVID Variants by Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos March 19, 2021
Medical Countermeasures mRNA Treatment Shows Promise for Stopping Flu and COVID-19 Viruses by Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos March 19, 2021
Medical Countermeasures Why We’ll Get COVID Booster Vaccines Quickly and How We Know They’re Safe by Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos March 19, 2021
Industry News OSU’s New Vaccine Candidate for COVID-19 Capitalizes on Measles Vaccine’s Successful History by Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos March 16, 2021
Medical Countermeasures New Evidence COVID-19 Antibodies, Vaccines Less Effective Against Worrisome Variants by Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos March 15, 2021
Medical Countermeasures AstraZeneca Vaccine: Careless Talk Has Dented Confidence and Uptake in Europe by Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos March 11, 2021
Medical Countermeasures WRAIR, Duke Scientists Find Evidence of Monoclonal Antibody Activity Against Malaria by Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos March 5, 2021
Industry News DARPA Awards Nucleic Acids On-Demand (NOW) Contract to GE Research and Collaborators by Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos March 2, 2021
Medical Countermeasures How Does the Johnson & Johnson Vaccine Compare to the Other Coronavirus Vaccines? by Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos March 2, 2021
Medical Countermeasures Key Questions About South Africa’s Vaccine Rollout Plan by Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos March 2, 2021
Medical Countermeasures Watch: BARDA Director Talks About Emergency Use Authorization of Third COVID-19 Vaccine by Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos March 1, 2021
Infectious Diseases How Do We Know the COVID Vaccine Won’t Have Long-Term Side-Effects? by Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos February 23, 2021
Industry News Thin Film Freezing Shows Efficacy for Biodefense Countermeasures Against Alphaviruses and Filoviruses by Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos February 19, 2021
Industry News BioFactura Funded $13M Contract Option for Smallpox Biodefense Therapeutic by Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos February 19, 2021
Medical Countermeasures Why Do SARS-CoV-2 Antibodies Fade, and Will the Same Thing Happen with Vaccines? by Anthony Zulli, Maja Husaric, Maximilian de Courten, and Vasso Apostolopoulos February 17, 2021
